Surmodics ROA 2006-2018 | SRDX

Current and historical return on assets (ROA) values for Surmodics (SRDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Surmodics ROA for the three months ending September 30, 2018 was 4.34%.
Surmodics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.01B $0.16B -3.22%
2018-06-30 $-0.00B $0.16B -2.02%
2018-03-31 $0.00B $0.16B 0.71%
2017-12-31 $0.00B $0.14B 0.00%
2017-09-30 $0.00B $0.14B 3.02%
2017-06-30 $0.01B $0.13B 5.33%
2017-03-31 $0.01B $0.13B 7.69%
2016-12-31 $0.01B $0.13B 7.83%
2016-09-30 $0.01B $0.13B 8.91%
2016-06-30 $0.01B $0.13B 7.83%
2016-03-31 $0.01B $0.12B 8.39%
2015-12-31 $0.01B $0.11B 11.06%
2015-09-30 $0.01B $0.10B 12.87%
2015-06-30 $0.01B $0.10B 13.72%
2015-03-31 $0.01B $0.09B 13.54%
2014-12-31 $0.01B $0.09B 12.34%
2014-09-30 $0.01B $0.11B 12.09%
2014-06-30 $0.01B $0.10B 14.21%
2014-03-31 $0.01B $0.10B 13.10%
2013-12-31 $0.02B $0.10B 14.67%
2013-09-30 $0.02B $0.10B 14.22%
2013-06-30 $0.01B $0.10B 13.21%
2013-03-31 $0.01B $0.11B 11.72%
2012-12-31 $0.01B $0.11B 9.16%
2012-09-30 $0.01B $0.10B 7.75%
2012-06-30 $-0.01B $0.16B -7.09%
2012-03-31 $-0.01B $0.15B -6.29%
2011-12-31 $-0.01B $0.15B -6.12%
2011-09-30 $-0.02B $0.16B -11.28%
2011-06-30 $-0.02B $0.17B -12.81%
2011-03-31 $-0.03B $0.17B -15.32%
2010-12-31 $-0.03B $0.17B -16.02%
2010-09-30 $-0.02B $0.17B -11.31%
2010-06-30 $0.00B $0.19B 2.11%
2010-03-31 $0.01B $0.19B 4.80%
2009-12-31 $0.01B $0.19B 7.02%
2009-09-30 $0.04B $0.19B 20.82%
2009-06-30 $0.03B $0.18B 18.50%
2009-03-31 $0.04B $0.18B 18.72%
2008-12-31 $0.04B $0.18B 19.17%
2008-09-30 $0.02B $0.19B 8.05%
2008-06-30 $0.00B $0.20B 1.10%
2008-03-31 $0.00B $0.19B 1.73%
2007-12-31 $0.00B $0.17B 2.47%
2007-09-30 $0.00B $0.17B 2.56%
2007-06-30 $0.02B $0.17B 15.69%
2007-03-31 $0.02B $0.14B 16.24%
2006-12-31 $0.02B $0.15B 12.90%
2006-09-30 $0.02B $0.16B 13.38%
2006-06-30 $0.02B $0.14B 13.46%
2006-03-31 $0.02B $0.14B 14.15%
2005-12-31 $-0.01B $0.13B -5.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.632B $0.081B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $119.905B 24.30
Medtronic (MDT) Ireland $113.823B 17.02
Stryker (SYK) United States $58.994B 22.24
Boston Scientific (BSX) United States $48.862B 24.69
Baxter (BAX) United States $35.185B 22.72
Zimmer Biomet Holdings (ZBH) United States $20.946B 13.58
Smith & Nephew SNATS (SNN) United Kingdom $16.239B 0.00
ResMed (RMD) United States $16.185B 30.86
Canopy Growth (CGC) Canada $9.865B 0.00
Bio-Rad Laboratories (BIO) United States $7.082B 45.28
Aurora Cannabis (ACB) Canada $6.767B 35.68
Perrigo (PRGO) Ireland $6.211B 9.43
Hill-Rom Holdings (HRC) United States $6.208B 19.42
Haemonetics (HAE) United States $5.043B 44.35
ICU Medical (ICUI) United States $4.661B 25.97
Insulet (PODD) United States $4.392B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.738B 0.00
Agios Pharmaceuticals (AGIO) United States $3.164B 0.00
Neogen (NEOG) United States $3.027B 46.50
Hutchison China MediTech (HCM) China $2.828B 0.00
National Vision Holdings (EYE) United States $2.347B 45.40
NuVasive (NUVA) United States $2.316B 21.55
Quidel (QDEL) United States $2.044B 26.65
NxStage Medical (NXTM) United States $1.917B 0.00
Aphria (APHA) $1.761B 78.33
Phibro Animal Health (PAHC) United States $1.288B 18.23
AtriCure (ATRC) United States $1.141B 0.00
VAREX IMAGING (VREX) United States $0.981B 19.65
Cardiovascular Systems (CSII) United States $0.966B 1390.00
Cerus (CERS) United States $0.767B 0.00
OraSure Technologies (OSUR) United States $0.731B 41.14
Meridian Bioscience (VIVO) United States $0.710B 22.64
PetIQ (PETQ) United States $0.695B 18.02
NanoString Technologies (NSTG) United States $0.668B 0.00
Lantheus Holdings (LNTH) United States $0.627B 19.39
Omeros (OMER) United States $0.619B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.616B 19.76
MacroGenics (MGNX) United States $0.571B 0.00
Quanterix (QTRX) United States $0.488B 0.00
Owens & Minor (OMI) United States $0.468B 5.29
LeMaitre Vascular (LMAT) United States $0.453B 22.25
Evolus (EOLS) United States $0.432B 0.00
TG Therapeutics (TGTX) United States $0.380B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.311B 20.10
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.302B 0.00
Vapotherm (VAPO) United States $0.281B 0.00
Bovie Medical (APYX) United States $0.274B 0.00
BioLife Solutions (BLFS) United States $0.228B 307.75
Cytosorbents (CTSO) United States $0.223B 0.00
Rockwell Medical (RMTI) United States $0.175B 0.00
Chimerix (CMRX) United States $0.151B 0.00
Surface Oncology (SURF) United States $0.139B 0.00
Fonar (FONR) United States $0.130B 6.53
Chembio Diagnostics (CEMI) United States $0.116B 0.00
United-Guardian (UG) United States $0.093B 19.56
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.87
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.032B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Myomo (MYO) United States $0.019B 0.00
Senestech (SNES) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00